Kevin D. Freeman, Director of Galectin Therapeutics GALT, has filed 10 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $58.6K. The latest trade was on 01/16.

KF

KF

Kevin D. Freeman

Director

Company

Galectin Therapeutics GALT

First filing

23/01/30

Trades

15 trades

Buys / sales

10 / 0

12-month net buying

$58.6K

Last trade

01/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Galectin TherapeuticsGALT	Open-market buy10b5-1 plan · Amendment	25/12/23	25/12/23	16,500 sh3 trades	$3.55avg.	$58,575	+42.6%
Galectin TherapeuticsGALT	Open-market buy	25/07/17	25/07/18	5,000 sh	$2.90	$14,500	+11.2%
Galectin TherapeuticsGALT	Open-market buy	24/12/24	24/12/26	10,000 sh	$0.81	$8,100	+28.8%
Galectin TherapeuticsGALT	Open-market buy	24/10/17	24/10/17	1,300 sh	$2.64	$3,432	+3.9%
Galectin TherapeuticsGALT	Open-market buy	24/10/16	24/10/16	10,000 sh2 trades	$2.70avg.	$27,000	No record
Galectin TherapeuticsGALT	Open-market buy	24/06/20	24/06/20	2,500 sh	$2.38	$5,950	+9.6%
Galectin TherapeuticsGALT	Open-market buy	24/04/22	24/04/22	2,500 sh	$2.98	$7,450	+10.7%